Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without

Y Zhang1, Z Qu, S Kim

  • 1Department of Pharmacology, Enzon Pharmaceuticals, Piscataway, NJ 08854,USA. yixian.zhang@enzon.com

Gene Therapy
|December 24, 2010
PubMed

Insights

Locked nucleic acid antisense oligonucleotides (LNA-ONs) effectively down-modulate target genes and proteins without delivery methods. This simplifies biological interpretation and identifies potential drug targets.

Area of Science:

  • Molecular Biology
  • Oligonucleotide Therapeutics

Background:

  • Traditional antisense molecules and small interfering RNAs require complex delivery methods for mRNA down-modulation.
  • These delivery methods can complicate the interpretation of biological outcomes.

Purpose of the Study:

  • To investigate the efficacy of locked nucleic acid (LNA)-based antisense oligonucleotides (LNA-ONs) for gene down-modulation without delivery agents.
  • To assess the speed, robustness, duration, specificity, and protein-level effects of LNA-ONs.
  • To explore the correlation between nuclear localization and LNA-ON efficiency.

Main Methods:

  • Utilized LNA-ONs in 30 different tumor cell lines.
  • Assessed gene and protein down-modulation.
  • Examined nuclear localization of LNA-ONs.
  • Tested LNA-ON efficacy in a tumor xenograft model for HER3 down-modulation.

Main Results:

  • LNA-ONs efficiently down-modulated target genes and proteins across multiple cell lines without delivery means.
  • Observed rapid, robust, long-lasting, and specific gene silencing.
  • Efficiency varied, with strongest effects in cells showing clear nuclear LNA-ON localization.
  • Successfully demonstrated HER3 mRNA and protein down-modulation in cells and a tumor xenograft model.

Conclusions:

  • LNA-ONs offer a simplified and effective approach for gene down-modulation, bypassing the need for delivery agents.
  • This platform facilitates the identification of potential drug targets and relevant animal models.
  • Understanding LNA-ON cellular uptake and trafficking mechanisms could enhance therapeutic applications for antisense molecules.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...